Dr. Merrill At American Uveitis Society Winter Symposium

Dr. Pauline Merrill presented data from MAGNOLIA, an extension study of PEACHTREE, a pivotal phase 3 clinical trial in patients with macular edema with non-infectious uveitis at the 2020 American Uveitis Society Winter Symposium in Park City, Utah. Her talk was on “Suprachoroidal Triamcinolone Acetonide and Intraocular Pressure: Results of Phase 3 PEACHTREE Clinical Trial for Uveitis”.